Search

Displaying results 1851 - 1860 of 10000 in total
  1. Drug

    Tocotrienol

    go.drugbank.com/drugs/DB12647
    Investigational

    Tocotrienol has been investigated for the treatment of Cholesterol Lowering.

    Mixtures: NHF Tocotrienol E Plus Vitamin D3 SoftgelCategories: Vitamin E, Heterocyclic Compounds, 1-Ring
  2. Drug

    Ibipinabant

    go.drugbank.com/drugs/DB12649
    Investigational

    Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    GSK-376501

    go.drugbank.com/drugs/DB12654
    Investigational

    GSK376501 has been used in trials studying the treatment and diagnostic of Type 2 Diabetes Mellitus.

  4. Drug

    JNJ-42396302

    go.drugbank.com/drugs/DB12657
    Investigational

    Jnj 42396302 is under investigation in clinical trial NCT01732237 (A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants).

  5. Drug

    Samatasvir

    go.drugbank.com/drugs/DB12660
    Investigational

    Samatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.

    Categories: Heterocyclic Compounds, 2-Ring
  6. Drug

    Indantadol

    go.drugbank.com/drugs/DB12664
    Investigational

    Indantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  7. Drug

    Icaritin

    go.drugbank.com/drugs/DB12672
    Investigational

    Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  8. Drug

    Lurbinectedin

    go.drugbank.com/drugs/DB12674
    ApprovedInvestigational

    the substitution of the tetrahydroisoquinoline with a tetrahydro β‐carboline that results in increased antitumour activity of lurbinectedin as compared to its predecessor. … Lurbinectedin is a DNA alkylating agent that has been investigated in the treatment of a variety of cancers, including mesothelioma,[A214325] chronic lymphocytic leukemia (CLL),[A214328] breast cancer,

    Categories: Cytochrome P-450 Substrates, P-glycoprotein inhibitors
  9. Drug

    Aviscumine

    go.drugbank.com/drugs/DB12684
    Investigational

    Cy 503 is under investigation in clinical trial NCT00658437 (Aviscumine for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy).

    Categories: N-Glycosyl Hydrolases
  10. Drug

    K-134

    go.drugbank.com/drugs/DB12685
    Investigational

    K-134 has been used in trials studying the treatment of Intermittent Claudication.

    Categories: Heterocyclic Compounds, 2-Ring